MCKENZIE COTTON: Open Payments
NPI 1023617594 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 35 payments from 16 companies in 2025. Trend: 2023 $1,565 · 2024 $1,082 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $188 |
| ABBVIE INC. | 10 | $179 |
| PFIZER INC. | 3 | $58 |
| Novo Nordisk Inc | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Boston Scientific Corporation | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: AIRSUPRA, QULIPTA, BREZTRI, VRAYLAR, PREVNAR 20, Ozempic, Kerendia, GARDASIL 9.
Industry payments across AR — which companies pay providers there.
